J. D. Hoff 2026-11-05
J. D. Hoff is an author of the 1983 study Hormonal dynamics at midcycle: a reevaluation by J. D. Hoff and others, which examined how hormones from the ovary and pituitary gland change around ovulation. Its contribution was a time-resolved comparison: samples from five participants were taken at two-hour intervals over five days, allowing changes in estradiol, progesterone, luteinizing hormone and follicle-stimulating hormone to be aligned around the onset of the luteinizing hormone surge.[ref]
That alignment exposed relationships which a single measurement could miss: the surge began abruptly near peak estradiol, while the rise in progesterone had already begun. The experiment supplied a temporal picture of the hypothalamic–pituitary–ovarian axis; temporal association by itself does not prove which change caused another. The cited paper identifies Hoff by initials, which are retained here.
Menstruation Created 2026-10-31 Updated 2026-11-05
Menstruation is cyclic shedding of blood and endometrium tissue through the vagina. During a human menstrual cycle, ovarian hormones regulate the growth and maintenance of the endometrium; a decline in hormonal support is followed by shedding when a pregnancy has not become established.[ref]
The first day of bleeding conventionally starts a new menstrual cycle. Menstruation describes a uterine event, whereas ovulation describes release of an oocyte from an ovary; treating the two as interchangeable obscures how the hypothalamic–pituitary–ovarian axis coordinates different organs.
Absent menstruation is a sign with several causes; treatment must distinguish physiological absence, failure of menstrual cycling and obstruction of outflow. The word “suppression” does not establish that retained blood is poisoning the body or that producing a bleed will cure the underlying problem.
First distinguish primary amenorrhoea, where menstruation has never begun, from secondary amenorrhoea, where established cycles have stopped. Ask about the previous pattern, possibility of pregnancy, breastfeeding, age, illness, nutrition, exercise, medicines and associated symptoms. Pregnancy, lactation and menopause can explain physiological absence. Pregnancy must be considered before any proposed menstrual stimulant, with assessment for complications when pain or abnormal bleeding accompanies the missed period.[ref]
A second group has impaired hormonal signalling or ovarian function. Severe illness, inadequate energy intake, major exertion and stress can suppress the hypothalamic–pituitary–ovarian axis. Other possibilities include thyroid disease, hyperprolactinaemia, primary ovarian insufficiency and chronic anovulation. These modern categories separate processes that an 1866 clinician might group under debility, constitutional disease or disordered ovarian activity. Anaemia and wasting deserve investigation and treatment when present, but are not universal explanations for every missed period.
A third group has an anatomical explanation. Cyclical pain with absent visible menstruation can indicate retained menstrual material behind an imperforate hymen or other outflow obstruction. Congenital absence or abnormal development of reproductive organs is different again. Acquired scarring of the uterine cavity may interrupt bleeding after instrumentation or disease. The response to obstruction is diagnosis-specific correction by an appropriate specialist; neither a “tonic” nor a drug intended to provoke uterine contraction repairs an absent or blocked passage.[ref]
In period terms, treatment of a genuine associated illness, improved nourishment and protection from exhausting conditions could be sensible. Warm baths and drugs called emmenagogues were also employed, but their use should not be mistaken for proof of efficacy, or attempted before excluding pregnancy. Menstrual absence should not automatically be interpreted as the cause of mental or systemic illness.
Modern correction: investigate the relevant physiological pathway and treat its cause. Selected investigations include a pregnancy test, prolactin, thyroid-stimulating hormone, ovarian and pituitary hormone measurements and pelvic ultrasonography. For functional hypothalamic suppression, restore energy availability and address contributing illness or disordered eating; simply imposing withdrawal bleeds can conceal persisting energy deficiency. Hormone replacement may be appropriate for ovarian insufficiency, while thyroid, prolactin-related and anatomical disorders need their own pathways. Management of chronic anovulation includes reproductive goals and protection of the endometrium, rather than just the appearance of regular bleeding.[ref][ref]